Otilonium Bromide Boosts Antimicrobial Activities of Colistin against Gram-Negative Pathogens and Their Persisters

Scientists identified an FDA-approved drug, Otilonium bromide, which restored the activity of colistin against colistin-resistant Gram-negative bacteria in vitro and in a mouse infection model.